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Objectives: During pregnancy, two aspects are critical in the context of adverse perinatal 
outcomes (APO): preconception obesity and gestational weight gain. This study aimed to 
assess compliance with the 2009 IOM guidelines, compare GWG with and without correcting 
for gestation duration, and observe the relationship between pre-pregnancy BMI and GWG 
and neonatal birth weight. 
Material and methods: This is a cross-sectional study conducted from 2015-2018 at the St. 
Sophia's Specialist Hospital in Warsaw, Poland. Self-reported pre-pregnancy and predelivery 
weight were collected. 
Results: The presented data set amounts to 7820 records. Analysis of weight gain compliance 
with IOM recommendations showed that only 41–44% (depending on the calculation method) 
of women had weight gain in accordance with IOM guidelines (22–23% — below; 33–37% 
— above). Overweight and obese women with diabetes are more likely to comply with IOM 
than women without diabetes. In contrast, women with normal-weight and underweight with 
diabetes are less likely to achieve IOM weight gain in pregnancy than women without 
diabetes. Women who have GWG below recommendations significantly more often gave 
birth to SGA neonates, and women who exceeded GWG standards significantly more often 
gave birth to LGA neonates. 
Conclusions: Less than half of women had GWG within the recommended norms. 
Statistically significant differences were found in methods of calculation of GWG, but it was 
not found clinically significant. Correction for pregnancy duration when calculating GWG 
reclassifies two percent of patients. We underestimate the risk of crossing the line between 
overweight and obesity during pregnancy.  
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The World Health Organization (WHO) has named obesity the most dangerous 
chronic disease of the current times. It is a multifactorial public health concern and a 
significant challenge of the 21st century. It is vital to acknowledge how maternal weight, diet, 
and physical activity shapes the intrauterine environment. Epigenetics raised awareness of the 
potential risks related to environmental factors shaping the following generations' health. 
Medical costs associated with treating diseases caused by obesity and overweight in 2025 
could reach 1.2 billion dollars [1–3]. 
During pregnancy, two aspects are critical in the context of adverse perinatal outcomes 
(APO). One is preconception obesity, and the second is gestational weight gain. Both 
independently increase the risk of infant adiposity, childhood obesity, glucose, insulin, and 
cardiometabolic dysregulation [4]. 
Already in 1950–60, the association between weight gain and pregnancy outcome was 
noted. Previously the recommended gestational weight gain did not exceed 7 kg and, if 
present, was associated with a high risk of preeclampsia. That limit was soon found to be 
insufficient in providing optimal perinatal outcome and was raised to 12 kg. The 1990 
Institute of Medicine (IOM) guidelines provided specific recommendations related to pre-
pregnancy BMI. With the growing global epidemic of obesity, those guidelines needed 
revision in 2009 [5]. The primary differences between the two documents were: use of WHO 
categories of pre-pregnancy Body Mass Index (BMI) instead of Metropolitan Life Insurance 
Company's ideal, development of ranges for gestational weight gain (GWG) for the second 
and third trimester. The latter has created specific goals for obese pregnant women. The goal 
ranged between 5–9 kg, instead of being at least 7 kg. The IOM guidelines are based 
primarily on observational data of associations [6, 7].  
Gilmore and Redman have presented a unified method of calculating gestational 
weight gain [1]. They have drawn attention to the fact that most studies estimate gestational 
weight gain without adjusting for gestational age. In their study, they compared four methods 
of calculating gestational weight gain. They showed that by adjusting for gestational age, 
there was a 40% increase in the number of cases with defined excess weight gain.  
 
Objectives 
This study's primary aim was to assess compliance with the 2009 IOM guidelines 
among term Polish pregnant women. We hypothesized that with the growing prevalence of 
 
 
overweight and obesity in Poland, the compliance would be inadequate, primarily among 
obese women. The secondary aim was to compare two methods of assessing GWG with and 
without correcting for gestation duration. We hypothesized that adjusting for pregnancy 
duration in term pregnancies (37–40 weeks) affects the classification of adherence to the IOM 
guideline. Thirdly we compared adherence to the IOM guideline in two groups with and 
without gestational diabetes (GDM). We hypothesized that the GDM group has better 
adherence to the guidelines. Finally, we looked at the relationship between pre-pregnancy 
BMI, GWG, and neonatal birth weight. We hypothesized that both higher pre-pregnancy BMI 
and GWG resulted in the birth of larger neonates.  
 
MATERIAL AND METHODS 
This is a cross-sectional study. Data was collected through the electronic database of 
the St. Sophia's Specialist Hospital in Warsaw, Poland. The study was conducted from 2015–
2018. All women at the obstetrics unit are offered a urogynecological consultation before 
discharge from the postpartum ward. They consented to a urogynecological examination and a 
brief medical history interview. As part of the survey, self-reported pre-pregnancy and 
predelivery weight was collected. This data was used for this study. These records were 
matched with other available patient electronic records, including age, parity, diabetes, 
hypertension, neonatal birth weight, and delivery mode. This data allowed a description of the 
demographic characteristics of the studied group.  
Inclusion criteria: pregnancy > 37 weeks (confirmed by LMP and first-trimester 
ultrasound), consent for an urogynecology examination and medical interview, complete self-
reported data on pre-pregnancy and predelivery weight. Exclusion criteria were preterm 
deliveries, multiple deliveries, incomplete data regarding weight and height, and 
pregestational diabetes. The study size was established after excluding patients that did not 
meet eligibility criteria.  
Pre-pregnancy and pre-delivery BMI were calculated from weight and height. The 
formula was weight in kilograms/height in meters2. According to WHO, each woman in the 
study group was classified into four BMI groups (Tab. 1). 
All data was imputed into a Microsoft Excel 365 calculation sheet (Microsoft 
Corporation, Redmond, USA). 
Gestational weight gain was calculated using two methods described by Gilmore and 
Redman. Method I is the most used for reporting GWG and adherence to the IOM guidelines. 
 
 
It is calculated by subtracting pre-pregnancy weight (PPW) from the predelivery weight 
(PDW) and comparing it to the IOM guideline of GWG at 40 weeks (GWG = PPW – PDW). 
Method II also subtracts pre-pregnancy weight from delivery weight but corrects for 
gestational age at delivery [GWG = (PPW – PDW/GA at delivery)* 40 weeks]. In this case, a 
weekly average weight gain was calculated by dividing the GWG by the number of pregnancy 
weeks at delivery. The average weekly weight was multiplied by 40 weeks and compared to 
the IOM at 40 weeks.  
Women were classified as adhering, being above or below IOM GWG guidelines by 
the two calculation methods (method I and method II). The calculations were made for the 
whole population and divided into two groups with and without gestational diabetes. 
Differences between classifications by the two methods depending on the pre-pregnancy BMI 
group were compared and analyzed. Secondly, the analysis was performed in two groups with 
and without gestational diabetes. 
The outcomes analyzed were number of women in each pre-pregnancy weight 
category, the number of women adhering to IOM guidelines depending on the method used 
for GWG and pre-pregnancy BMI; differences in adherence to IOM guidelines in women with 
and without gestational diabetes; effect of pre-pregnancy BMI and GWG on neonatal birth 
weight. Centiles for neonatal birthweight were calculated based on the Fenton growth chart, 
and neonates were classified as SGA, AGA, LGA [8]. 
Women recruited into the study self-reported their pre-pregnancy and delivery weight. 
The interviewer verified the self-reported data with the data given upon admission to the 
hospital and recorded during prenatal visits in the patient's prehospitalization pregnancy 
documents. This minimized the risk of recall bias. Only women who agreed to a 
urogynecological exam participated in the study, which may be a selection bias source.  
The STROBE guideline was used as a reporting guideline to ensure a clear and complete 
report of the study's design, conduct, and findings. The study was approved by the Centre of 
Postgraduate Medical Education Bioethics Committee (Decision No. 47/PB/2018). Patients 
consented to participation in the study.  
 
Statistical methods 
The data was analyzed using Dell Inc. (2016). Dell Statistica (data analysis software 
system), version 13, and R Statistical Software (Foundation for Statistical Computing, 
Vienna, Austria). Shapiro-Wilk test confirmed compliance with a normal distribution. 
 
 
Qualitative data were presented as frequency (percentage). Group comparison was performed 
using ANOVA type Kruskal-Wallis test. For statistically significant results, posthoc tests of 
Multiple Rank Average Comparisons were done. Quantitative data correlations were checked 
using rho-Spearman. To compare quantitative data in groups of women with and without 
diabetes Mann-Whitney U test was used. Differences in GWG calculated by the two methods 
were assessed with the multinominal test. The level of statistical significance was assumed as 
p < 0.05. 
 
RESULTS 
Eight thousand one hundred fifty-nine records were available for analysis. We 
excluded from the study preterm deliveries, pregestational diabetes, multiple deliveries, and 
incomplete data regarding weight and height (n = 339). In the final analysis, there were 7820 
complete records. 
The characteristics of the study population are presented in table 2. The average age of 
the surveyed women was 31.22 (SD 4.36) years. There were no significant differences 
between the mean age in the studied groups. Most patients were primiparas (41.62%), para 
two (36.45%), para three (13.50%), and para four (8.43%) comprised the rest of the 
respondents. BMI increased with parity (p = 0.000). The post-test showed that BMI increases 
significantly between para 1 and 3. In para more than 3, there are no significant differences. 
But GWG does not change significantly with each subsequent birth.  
Among women in the studied group, 27.44 had hypothyroidism, and 7.44% had 
pregnancy diabetes. Overweight and obese women had a significantly higher incidence of 
GDM (13.38% and 29.03%, respectively). The average birth weight was 3472 grams and 
differed considerably depending on maternal BMI. The largest average neonatal birth weight 
was observed in overweight and obese mothers (3578 and 3548 grams, respectively). Children 
of underweight mothers had the lowest average birth weight (3327 grams). In the studied 
group, there was a slightly higher number of boys than girls. BMI did not affect fetal sex. 
(Tab. 2) 
The average pregnancy weight gain was 14.23 kg, and the average weekly weight gain 
was 0.36 kg. The values differed significantly depending on pre-pregnancy BMI (Tab. 3). 
Analysis of compliance of weight gain with IOM recommendations using method I showed 
that only 43.63% of women had weight gain in accordance with IOM guidelines (22.99% — 
 
 
below; 33.32% — above). Mostly in accordance with the recommendations were underweight 
(52%) and normal weight (47%) women. Among overweight and obese patients, only 25% 
were compliant with IOM. Above IOM guidelines were 68% of overweight and 56% of obese 
women. Below IOM guidelines were primarily underweight (37%) and normal weight (24%) 
women (Tab. 3). 
An analogous analysis was performed using method II (Tab. 3). A multinomial test 
revealed that compliance differed significantly depending on the method used (p < 0.05).  
The average weight gain in pregnancy is significantly (p < 0.001) lower in the group of 
women with diabetes than in women without diabetes. The most statistically significant 
difference (3.44 kg) is in the group of obese women and the smallest (2.66 kg) in the group of 
normal-weight women (p < 0.001) (Tab. 4). 
Only 32% of all women with gestational diabetes were in accordance with IOM 
guidelines. Overweight and obese women with diabetes are more likely to comply with IOM 
than women without diabetes. In contrast, women with normal weight and underweight with 
diabetes are less likely to achieve IOM weight gain in pregnancy than women without 
diabetes. More women classify below the recommended GWG and less above the 
recommended GWG than women without diabetes (Fig. 1 and Fig. 2). 
Spearman's correlation showed a statistically significant but weak relationship 
between pregnancy weight gain and neonatal birthweight (Rs = 0.23; p < 0.05). In all pre-
pregnancy weight categories, the correlation results were statistically significant. Weak 
correlation occurred in the normal weight (Rs = 0.25) and underweight (Rs = 0.28) groups. In 
the overweight and obese groups, the correlation was very weak. 
Comparing the GWG and neonatal birthweight showed that the birthweight differed 
significantly depending on compliance to weight gain recommendations in the underweight 
and normal-weight group. In these two groups, women with weight gain below recommended 
GWG gave birth to significantly smaller children than women with normal and above 
recommended GWG (Tab. 5). Women with diabetes gave birth to significantly (p < 0.001) 
smaller children (M = 3399 g) than women without diabetes (M = 3479 g). 
Underweight women are significantly more likely to give birth to SGA neonates. In 
contrast, obese and overweight women are significantly more likely to give birth to LGA 
neonates (12% — obese, 10% — overweight) (Tab. 1). Women who have GWG below 
recommendations significantly more often give birth to SGA neonates, and women who 
exceeded GWG standards significantly more often give birth to LGA neonates. 
 
 
Simultaneously, 2–3% of women with excess weight gain gave birth to SGA neonates, and 
those that gained below recommendations gave birth to LGA neonates. (Tab. 6) 
 
DISCUSSION 
WHO report from 2019 ranks Poland 85th in the world, with 23.1% of the population 
classified as obese. The USA is ranked 18th, with 36.2% of obese adults [2, 9]. In Poland's 
published data of the General Office of Statistics (GUS) in 2014, 16.7% of adults were obese 
and 36.6% overweight adults. 15.6 % of women were obese, according to GUS [10].  
According to the NCD Risk Factor Collaboration (NCD-RisC), 3 out of 5 adult 
citizens in Poland are overweight, and one out of four is obese. The scale of the problem is 
increasing. The prognosis is that by 2025 25.9% of women will be obese, a 10% increase to 
the current statistics [11]. 
From a European perspective, Poland ranks 11th among 20 European countries 
included in the cohort studied by Marques et al., 34 814 participants had BMI calculated and 
ranked. The highest prevalence of overweight women was in Czech (45.2%), Hungary 
(43.7%), and Lithuania (41.7%). Obesity was most prevalent in Slovenia (20.8%), Estonia 
(19.7%) and Great Britain (19.2%) [12]. 
With the growing prevalence of overweight and obesity in our study population, we 
have observed insufficient adherence to the IOM guidelines, especially by overweight 
women. In our study, 15.51% of patients were overweight or obese. Obese women were 
3.17% of the group. This number, which is smaller than the country's reported obesity rate, 
can be explained by the fact that obese women with a BMI > 35 have a higher infertility rate 
than normal-weight women [13]. Overweight and obese women accounted for 42.41% of 
GDM. Interestingly these women with GDM had much better adherence to IOM guidelines 
than overweight and obese women without GDM, which shows how an intervention such as 
diet can affect GWG [14]. Surprisingly, the highest number of women that classified as above 
IOM recommendations was among overweight women without GDM. The same results for 
GWG among overweight and obese women were obtained in the study by Zhao et al., 
(Chinese population) [13]. In contrast, Thapa & Paneru presented that 57% of overweight 
women had GWG consistent with the IOM (Nepalese population, small study, 227 women) 
[14]. Similar results were published by Diemert et al., [15]. The fact that overweight women 
are more at risk of not fitting the IOM guidelines was a result that differed from our initial 
hypothesis. This is a group of women where there is the highest potential for intervention. 
 
 
Since in our study BMI increased with parity, these are women that could be at risk of being 
obese in subsequent pregnancies. This shows that education regarding GWG among 
overweight patients without GDM is currently insufficient [5, 15]. Since GWG does not 
increase in parity in this study, the greatest threat is not returning to pre-pregnancy weight 
between pregnancies.  
A meta-analysis showed that mothers are motivated to take measures that could affect 
their child's wellbeing but are not always aware of the importance of GWG on children's 
health. Therefore, it is necessary to educate women in this area by doctors and midwives, 
although this analysis has shown this task a difficult task because it is a sensitive topic [17].  
Adjusting pregnancy duration in term pregnancies (37–40 weeks) does not significantly affect 
adherence to IOM guidelines rendering only a 2% difference between the two methods. We 
tested two methods of calculating GWG. The application of method II resulted in fewer 
patients fitting in the recommended guidelines. This arises from the fact that more than 50% 
delivered before 40 weeks' gestation. In every group, two percent more cases did not fit in the 
recommended guidelines. In their original paper, Gilmore and Redman showed a 40 % change 
in the qualification of adherence to IOM guidelines after correcting for gestational age. This 
could result from their model being a theoretical one and was not tested on either 
retrospective or a prospective population [1]. Perhaps if this analysis were made for preterm 
deliveries, the difference would be more significant. This aspect needs further assessment.  
Finally, we looked at the relationship between pre-pregnancy BMI and GWG and birth 
weight. Pre-pregnancy BMI and excess GWG are risk factors for macrosomia [16, 17]. 
Previous reports have concentrated on SGA, AGA, and LGA rates related to BMI and GWG 
[14]. Similarly, there was a correlation between increased BMI and GWG and LGA and 
decreased BMI and GWG and SGA in this study. An interesting group of patients in the 
neonatal outcome would be the 2–3% of SGA in obese women and LGA in underweight 
women. This combination warrants further research. Although, it suggests that other factors 
are affecting fetal growth. We found a weak correlation between gestational weight gain and 
neonatal birth weight in the context of birthweight itself. But being below IOM guidelines in 
underweight and normal-weight women affected neonatal birthweight. These neonates were 
statistically smaller in this group.  
Interestingly this effect was not observed at all in obese women. Identical results 
published Thapa and Paneru [18]. Compared to pre-pregnancy BMI that is confirmed to 
 
 
correlate with neonatal birthweight – our study confirms conclusions from previous studies 
based on IOM [18–20].  
This study presents a large group of pregnant women that have self-reported their 
pregnancy-related weight. This allowed for the assessment of GWG and verification of the 
two methods of calculation. Secondly, we showed how the diagnosis of GDM and the medical 
care that follows, including diet, affects GWG and its correlation with fitting the IOM 
guidelines — leading to the conclusion that in most GDM women, the IOM guidelines 
underestimate GWG. Perhaps there should be separate GWG guidelines for women with 
diabetes.  
This was a weight self-reported retrospective study, making it a potential for bias. 
There is a risk of recall and reporting bias for self-reported pregnancy related weight. 
Fortunately, previous studies have shown that this risk is not that significant [21]. Phelan et al. 
[22]showed a high level of agreement between self-reported preconception weight and 
available clinical record of preconception weight gathered in the last year. According to a 
systematic review published by Headen et al. [23], although measured weight is preferable, 
self-report is a cost-effective and practical measurement approach. They point out the need to 
develop bias correction techniques for self-reported pregnancy-related weight. We could not 
analyze adverse perinatal outcomes due to the risk of selection bias. Women that participated 
in the study were women that consented to a postpartum urogynecological examination. These 
were primarily women that delivered vaginaly. For this reason, the study only included 
women in term pregnancies > 37 weeks gestation. To reach the study's aims, the discussed 
sources of selection bias have potentially little effect on the investigation results. 
 
CONCLUSIONS 
Less than half of women had GWG within the recommended norms. Statistically 
significant differences were found in methods of calculation of GWG, but it was not found 
clinically significant. Correction for pregnancy duration when calculating GWG reclassifies 
two percent of patients. Being below or above the recommended GWG resulted in an 
increased risk of SGA and LGA, respectively. We underestimate the risk of crossing the line 
between overweight and obesity during pregnancy. Both patients and medical professionals 
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Figure 1. Compliance to weight gain recommendations — women without GDM (method I)  
 









Body Mass Index Recommended Range 
of Weight Gain [kg] 
Underweight Less than 18.5 12.5–18 
Normal Weight 18.5–24.9 11.5–16 
Overweight 25–29.9 7–11.5 









Overweight Obese All p 
N (% of total) 730 (9.34) 5885 (75.26) 957 (12.24) 248 (3.17) 7820 (100)  
Mean age (SD) 30.45 (4.55) 31.22 (4.28) 31.71 (4.50) 31.65 (4.65) 31.22 (4.36) 0.000 
GDM (% of group) 46 (6.30) 336 (5.71) 128 (13.38) 72 (29.03) 582 (7.44) 0.000 
GDM 1  40 (5.48) 275 (4.67) 86 (8.99) 36 (14.52) 437 (5.59) 0.000 
GDM 2  6 (0.82) 61 (1.04) 42 (4.39) 36 (14.52) 145 (1.85) 0.000 
Hypothyroidism (% of 
group) 




(% of group) 
7 (0.96) 83 (1.41) 46 (4.81) 24 (9.86) 160 (2.05) 0.000 
Prepregnancy 
hypertension (% of group) 
3 (0.41) 16 (0.05) 11 (0.31) 11 (1.21) 41 (0.52) 0.000 








































Mean Birth weight (SD) 
[gr]  
3327 (394) 3470 (418) 3578 (431) 3548 (433) 3472 (422) 0.000 
FENTON (% of group)      0.000 
SGA 70 (9.58) 307 (5.22) 32 (3.34) 9 (3.63) 418 (5.35)  
AGA 648 (88.77) 5272 (89.58) 828 (86.52) 208 (83.87) 6956 
(88.95) 
 
LGA 12 (1.64) 306 (5.20) 97 (10.14) 31 (12.50) 446 (5.70)  
 
 
Table 2. The characteristics of the study population divided into groups 
SD — standard deviation; GDM — gestational diabetes; SGA — small-for-gestational-age; 

















































Mean weight gain per week 
(SD) [kg] 
0.35 (0.10) 0.37 (0.11) 0.35 (0.14) 0.26 
(0.18) 
0.36 (0.12) 0.000 
METHOD I 
Women with weight gain below 
recommended (% of group) 





Table 3. Compliance with weight gain recommendations (methods I and II)  
Women with weight gain 
compliant to recommended (% 
of group) 
376 (51.50) 2742 (46.60) 236 
(24.66) 
62 (25.00) 3416 
(43.68) 
 
Women with eight gain above 
recommended (% of group) 








Women with weight gain 
below recommended (% of 
group) 
254 (34.80) 1336 (22.70) 71 (7.42) 48 (19.36) 1709 
(21.85) 
0.000 
Women with weight gain 
compliant to recommended (% 
of group) 
380 (52.05) 2533 (43.05) 221 
(23.09) 
55 (22.17) 3189 
(40.78) 
 
Women with weight gain 
above recommended (% of 
group) 









 Table 4. Mean weight gain women with and without GDM 
SD — standard deviation; GDM — gestational diabetes 
  







All women 14.47 (4.53) 11.19 
(5.24) 
0.00 
Underweight women 14.01 (3.99) 10.96 
(4.08) 
0.00 
Normal Weight women 14.66 (4.31) 12.00 
(4.61) 
0.00 
Overweight women 14.25 (5.36) 11.00 
(5.58) 
0.00 
 Obese women 11.28 (6.95) 7.84 (6.63) 0.00 
 
 
Table 5. Mean birth weight depending on the pre-pregnancy body mass index and 
compliance to Institute of Medicine 
 
 
Table 6. Accordance with Institute of Medicine guidelines vs SGA/AGA/LGA 














n = 2922 (%) 
ALL 
n = 7820 (%) p 
SGA 149 (8.72) 185 (5.80) 84 (2.87) 418 (5.35) 0.000 
AGA 1523 (89.12) 2874 (90.12) 2560 (87.61) 6956 (88.95)  
LGA 37 (2.17) 130 (4.08) 278 (9.51) 446 (5.70)  
SGA — small-for-gestational-age; AGA — appropriate-for-gestational-age; LGA — large-
for-gestational-age  















Underweight women 3230 3353 3481 0.00
0 
Normal Weight women 3334 3457 3601 0.00
0 
Overweight women 3435 3549 3603 0.05
5 
Obese women 3528 3458 3589 0.13
5 
